- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Hypomagnesaemia |
|---|
|
| Prevention of hypomagnesemia |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Has a laxative effect at dosages of above 2 ml/kg/day.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Sodium | ||
|---|---|---|
| A12CA01 | ||
| Zinc | ||
|---|---|---|
| A12CB01 | ||
| Magnesium | ||
|---|---|---|
| A12CC05 | ||
| A12CC01 | ||
| A12CC03 | ||
| A12CC02 | ||
| Selenium | ||
|---|---|---|
| A12CE02 | ||
| Other mineral products | ||
|---|---|---|
| A12CX | ||
| MAGNESIUM | ||
|---|---|---|
| A12CC05 | ||
| A12CC01 | ||
| A12CC03 | ||
| A12CC02 | ||
| OTHER MINERAL PRODUCTS | ||
|---|---|---|
| A12CX | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
- Kora Corporation Ltd t/a Kora Healthcare, SmPC Magmedi (RVG 126098) 15-2-2023, Geneesmiddeleninformatiebank.nl
- Editorial Board Kinderformularium, Expert opinion, based on conversion of other (licensed) magnesiumsalts, , Board meeting Sept 7, 2022
- Editorial Board Kinderformularium, Expert opinion, based on conversion of other (licensed) magnesiumsalts,, Board meeting Sept 7, 2022
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
